• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Home
  • Latest
  • Videos
  • Series
  • E-Newsletters
    • Fat Tail Daily
    • James Cooper’s Mining Memo
    • The Daily Reckoning Australia
  • Categories
    • Commodities
    • Macro
    • Market Analysis
    • Small Caps
    • Technology
  • Investment Guides
  • Premium Services
  • Editors
  • About
  • Contact Us
Fat Tail Daily
Subscribe
  • Home
  • Latest
  • Videos
  • E-Newsletters
  • Premium Services

Biotech Stocks: Investing in Cutting-Edge Healthcare Innovations

ASX ADO - AnteoTech Share Price

AnteoTech Share Price Jumps on Tax Incentive (ASX:ADO)

At the time of writing the AnteoTech Ltd [ASX:ADO] share price trades at 10.5 cents, up 5%. AnteoTech announced the company received a cash refund, under the Federal Government’s research and development tax incentive scheme…

By Carl Wittkopp, Friday, 27 November 2020

ASX IMU - Imugene Share Price

Imugene Share Price Lifts as Fresh Results Show Promise (ASX:IMU)

The Imugene Ltd [ASX:IMU] share price is trading 15% higher at time of writing. Rising on the back of new news from the biotech’s phase 2 trial. In what is now just the latest leg up for the company in the past month…

By Ryan Clarkson-Ledward, Monday, 23 November 2020

Mesoblast Share Price - ASX MSB

Mesoblast Share Price Up on Novartis Collaboration (ASX:MSB)

At time of writing, the share price of Mesoblast Ltd [ASX:MSB] is up more than 14%, to trade at $3.73. We take a look at the details of Mesoblast’s latest announcement to work with pharma giant on remestemcel-L commercialisation

By Lachlann Tierney, Friday, 20 November 2020

Kazia Therapeutics Share Price - ASX KZA

Kazia Therapeutics Share Price up 32% as It Confirms Positive Results

The Kazia Therapeutics Ltd [ASX:KZA] share price is following an upward trend. While this small-cap biotech may not be trying to treat COVID, they are trying to treat an equally sinister disease: glioblastoma.

By Ryan Clarkson-Ledward, Wednesday, 18 November 2020

Second Order Effects on Stock Market

More Positive Vaccine News and Second-Order Effects on the Market

Consequences of consequences, synthetic biology just getting started In this case. The money flowing towards these companies could be the launching pad for an entirely new field of science called synthetic biology…

By Lachlann Tierney, Tuesday, 17 November 2020

ASX ATH Share Price - Alterity Therapeutics Share Price

Alterity Therapeutics Share Price Roars 27% Higher on US Patent

Once again, small biotech stocks are making big headlines. Alterity Therapeutics Ltd [ASX:ATH] is kicking things off this week with some great news. Updating the market on its US patent proceedings…

By Ryan Clarkson-Ledward, Monday, 16 November 2020

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Interim pages omitted …
  • Page 28
  • Go to Next Page »

Primary Sidebar

Technology Categories

  • Technology
  • Artificial Intelligence
  • Bitcoin
  • Cryptocurrency
  • Energy
  • Financial Technology
  • Bio Technology

Footer

Fat Tail Daily Logo
YouTube
Facebook
x (formally twitter)
LinkedIn

About

Investment ideas from the edge of the bell curve.

Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.

Quick Links

Subscribe

About

FAQ

Terms and Conditions

Financial Services Guide

Privacy Policy

Get in Touch

Contact Us

Email: support@fattail.com.au

Phone: 1300 667 481

All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.

Fat Tail Logo

Fat Tail Daily is brought to you by the team at Fat Tail Investment Research

Copyright © 2026 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988